Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical StudiesYifan Zhai, Qiuqiong Tang, Douglas D Fang, et al.European Journal of Cancer (Oxford, England : 1990)|February 17, 2010
MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 functionAsfar S Azmi, Amro Aboukameel, Sanjeev Banerjee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2023
First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid TumorsNehal J Lakhani, Drew Rasco, Hengbang Wang, et al.Annals of Hematology|March 31, 2007
A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cellsManchao Zhang, Yan Ling, Chao-Yie Yang, et al.Cell Death Discovery|May 4, 2021
MDM2 inhibitor APG-115 exerts potent antitumor activity and synergizes with standard-of-care agents in preclinical acute myeloid leukemia modelsDouglas D Fang, Qiuqiong Tang, Yanhui Kong, et al.Blood|February 23, 2008
Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphomaLuca Paoluzzi, Mithat Gonen, Jeffrey R Gardner, et al.Journal of Medicinal Chemistry|November 26, 2009
Potent and orally active small-molecule inhibitors of the MDM2-p53 interactionShanghai Yu, Dongguang Qin, Sanjeev Shangary, et al.International Journal of Oncology|June 13, 2014
Apogossypolone, a small-molecule inhibitor of Bcl-2, induces radiosensitization of nasopharyngeal carcinoma cells by stimulating autophagyJin-Hua He, Xiao-Li Liao, Wei Wang, et al.Journal of Medicinal Chemistry|May 9, 2013
A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in miceRong Sheng, Haiying Sun, Liu Liu, et al.BMC Cancer|November 9, 2014
Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patientsMiaozhen Qiu, Yixin Zhou, Xinke Zhang, et al.Pageof 12